Rapid Adventitious Agent Testing Remains a Real Need

Media Coverage
More advanced NGS-based techniques still require validation and regulatory acceptance.

BioPharm International

In-vivo assays encounter the same challenges and limitations, and there is a high failure rate due to the route for test sample administration. Studies have also shown a low detection rate for these tests compared to in-vitro assays, according to Ruppach.

Testing methods are constantly changing, Horst Ruppach, Director of Viral Clearance and Virology, shares his unique commentary in BioPharm International regarding the changes in testing methods.

READ THE FULL ARTICLE